
Anna-Birgitte Aga
- Postdoc; MD, PhD
- +47 404 70 692
Senior consultant in pediatric rheumatology
Publications 2023
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Ann Rheum Dis (in press)
DOI 10.1136/ard-2023-224476, PubMed 37607809
Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control
JAMA, 329 (12), 1024-1026
DOI 10.1001/jama.2023.0492, PubMed 36976288
Associations between power Doppler ultrasound findings and B-mode synovitis and clinical arthritis in juvenile idiopathic arthritis using a standardised scanning approach and scoring system
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002937, PubMed 36963783
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Ann Rheum Dis, 82 (10), 1286-1295
DOI 10.1136/ard-2023-224116, PubMed 37423647
Publications 2022
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD
J Rheumatol, 50 (4), 538-547
DOI 10.3899/jrheum.220645, PubMed 36379571
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
RMD Open, 8 (1)
DOI 10.1136/rmdopen-2021-002013, PubMed 35091463
The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational study
Arthritis Res Ther, 24 (1), 183
DOI 10.1186/s13075-022-02874-y, PubMed 35932087
Publications 2021
MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients
Front Immunol, 12, 663736
DOI 10.3389/fimmu.2021.663736, PubMed 33897713
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment
Ann Rheum Dis, 81 (3), 344-350
DOI 10.1136/annrheumdis-2021-220750, PubMed 34389605
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
JAMA, 325 (17), 1755-1764
DOI 10.1001/jama.2021.4542, PubMed 33944875
Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis
Ann Rheum Dis, 80 (11), 1493-1494
DOI 10.1136/annrheumdis-2021-220265, PubMed 34083205
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis
RMD Open, 7 (2)
DOI 10.1136/rmdopen-2021-001581, PubMed 33883255
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy
RMD Open, 7 (1)
DOI 10.1136/rmdopen-2020-001525, PubMed 33547228
Publications 2020
Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T Cells
Front Immunol, 11, 194
DOI 10.3389/fimmu.2020.00194, PubMed 32117312
Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategies
Arthritis Rheumatol, 72 (7), 1072-1081
DOI 10.1002/art.41232, PubMed 32090491
Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis
Rheumatology (Oxford), 59 (9), 2550-2555
DOI 10.1093/rheumatology/kez674, PubMed 31999341
Publications 2019
Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis
Scand J Rheumatol, 49 (2), 87-95
DOI 10.1080/03009742.2019.1641216, PubMed 31544586
Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS)
J Rheumatol, 46 (9), 1222-1227
DOI 10.3899/jrheum.181064, PubMed 30770509
Assessing synovitis in the hands in patients with rheumatoid arthritis by ultrasound: an agreement study exploring the most inflammatory active side from two Norwegian trials
Arthritis Res Ther, 21 (1), 166
DOI 10.1186/s13075-019-1930-y, PubMed 31277679
Publications 2018
Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC study
RMD Open, 4 (2), e000754
DOI 10.1136/rmdopen-2018-000754, PubMed 30487996
The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy
Arthritis Res Ther, 20 (1), 146
DOI 10.1186/s13075-018-1635-7, PubMed 30001740
Response to: 'Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis' by Chevreau et al
Ann Rheum Dis, 77 (12), e85
DOI 10.1136/annrheumdis-2017-212869, PubMed 29321158
The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis: Secondary Analyses From a Randomized Trial Examining the Benefit of Ultrasound in a Clinical Tight Control Regimen
Arthritis Rheumatol, 70 (8), 1192-1199
DOI 10.1002/art.40494, PubMed 29575737
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
RMD Open, 4 (2), e000752
DOI 10.1136/rmdopen-2018-000752, PubMed 30564452
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes
Ann Rheum Dis, 77 (10), 1421-1425
DOI 10.1136/annrheumdis-2017-212830, PubMed 29934373
Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol
Rheumatology (Oxford), 57 (11), 2022-2031
DOI 10.1093/rheumatology/key202, PubMed 30053199
Publications 2017
[Not Available]
Tidsskr Nor Laegeforen, 137 (6), 471
DOI 10.4045/tidsskr.16.1120, PubMed 28332809
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis
Ann Rheum Dis, 76 (12), 2031-2037
DOI 10.1136/annrheumdis-2017-211695, PubMed 28814431
Publications 2016
Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach
RMD Open, 2 (2), e000325
DOI 10.1136/rmdopen-2016-000325, PubMed 28074154
Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial
BMJ, 354, i4205
DOI 10.1136/bmj.i4205, PubMed 27530741
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria
Ann Rheum Dis, 76 (2), 341-345
DOI 10.1136/annrheumdis-2015-208873, PubMed 27094444
Publications 2015
First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach
Ann Rheum Dis, 75 (8), 1444-51
DOI 10.1136/annrheumdis-2015-207572, PubMed 26085490
Publications 2013
Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010
Ann Rheum Dis, 74 (2), 381-8
DOI 10.1136/annrheumdis-2013-204020, PubMed 24285493
Publications 2001
Juvenile nasopharyngeal angiofibroma presenting as Foster Kennedy Syndrome
Ethiop Med J, 39 (3), 251-60
PubMed 11921556
Publications 1989
[Cases of serous otitis admitted to the ENT Department of the V. Babeş Hospital over the last 7 years]
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol, 34 (1), 57-62
PubMed 2528792
Publications 1946
[Improved dropper for ether anesthesia]
Khirurgiia (Mosk) (7), 87-9
PubMed 20283318